Pasquale P. Filardi, Italy
Federico II University Hospital Acute Heart Failure , Nuclear Imaging, Risk Factors and Prevention, Coronary Artery Disease Chronic, Myocardial Disease
Presenter of 2 Presentations
LIVE Panel discussion: with a focus on very-high risk patients
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
14:30 - 16:00
Lecture Time
15:28 - 15:53
[{"name":"LIVE Panel discussion: with a focus on very-high risk patients","mode":"playlist","public":true,"info":{"id":1749,"presentation":"LIVE Panel discussion: with a focus on very-high risk patients","session":"Not included in the main CME-CPD of the event","presenter":"Fran\u00e7ois Mach, Switzerland, Kausik K. Ray, United Kingdom, Chris Packard, United Kingdom, Ulrich Laufs, Germany, Pasquale P. Filardi, Italy","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/Targeting PCSK9.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/111\/Targeting PCSK9.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/4F94738A.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0wa"}
[session]
[presentation]
[presenter]
Hide
PCSK9 inhibitors; what can we learn from 5 years of real-world experience?
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
14:30 - 16:00
Lecture Time
15:12 - 15:28
[{"name":"PCSK9 inhibitors; what can we learn from 5 years of real-world experience?","mode":"playlist","public":true,"info":{"id":1748,"presentation":"PCSK9 inhibitors; what can we learn from 5 years of real-world experience?","session":"Not included in the main CME-CPD of the event","presenter":"Kausik K. Ray, United Kingdom, Pasquale P. Filardi, Italy","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/1332.jpg"},"playlist":[{"name":"PCSK9 inhibitors what can we learn from 5 years of real-world experience","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/Ray And Filardi EAS20 PCSK9 inhibitors what can we learn from 5 years of real-world experience.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/111\/Ray And Filardi EAS20 PCSK9 inhibitors what can we learn from 5 years of real-world experience.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/111\/50459271.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Xi0w9"}
[session]
[presentation]
[presenter]
Hide